Gregory D. Longmore, M.D.

Greg Longmore
  • Professor
    • Department of Medicine
      • Hematology Division
    • Department of Cell Biology & Physiology
  • Clinical interests
    • Hematology
  • Research interests
    • Epithelia morphogenesis
    • Cancer metastasis

Research

In general, we are interested in understanding how extracellular signals, including cell adhesive events, are transduced inside cells to influence the cellular cytoskeleton so as to effect cell motility. Our approach to this problem has been biochemical, cell biologic, genetics, and cellular imaging - both static and dynamic and in 2- and 3-dimensional systems. We are developing computational models of signaling pathways that regulate cell migration and are amenable to experimental manipulation, so as to identify and quantify interactions between these processes during cell migration.

Epithelia are cellular barriers that protect our bodies (inside and out) from environmental insults. Their development, organization, and maintenance are critical for normal homeostasis. We are interested in understanding how epithelia form and remodel during development, how they are organized, and how they are maintained in the adult. Our approach to this problem is cell biologic and genetic. To do so we make use of multiple organisms (Xenopus, drosophila, and mouse). During epithelia-derived cancer invasion (metastasis), early tumors de-adhere from one another and acquire the capacity to migrate or invade through the basement membrane, leading to spread throughout the body. This process has been morphologically, functionally, and genetically described as an epithelial-mesenchymal transition or EMT. While EMT is a normal process during development, in the adult it occurs in pathologic conditions such as organ fibrosis in response to injury, and cancer metastasis. We are interested in understanding the molecular and cellular mechanisms regulating EMT. Specifically, how cell surface adhesive events communicate with nuclear responses to initiate, maintain, and terminate EMT changes.

Ajuba

Ajuba is rapidly recruited to newly formed cell-cell contacts in keratinocytes

From: Marie H, Pratt SJ, Betson M, Epple H, Kittler JT, Meek L, Moss SJ, Troyanovsky S, Attwell D, Longmore GD, Braga VM
The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin.
J Biol Chem 2003 Jan 10;278(2):1220-8

Biographical Sketch

Education

1973-1977 B.Sc. (Honours) Biochemistry, University of Western Ontario, London, Ontario
1977-1979 M.Sc. Biochemistry, University of Toronto, Toronto, Ontario
1979-1983 M.D., C.M. Medicine, McGill University, Montreal, Quebec
1983-1990 Clinical Fellow, Internal Medicine and Hematology-Oncology, Harvard Medical School, Boston, MA
1989-1993 Postdoctoral Research Fellow, Cell Biology, Massachusetts Institute of Technology, Cambridge, MA

Academic Positions & Training

1977-1980 Predoctoral Student, Department of Biochemistry, University of Toronto, Ontario (laboratory of Dr. Harry Schachter)
1983-1986 Clinical Fellow in Internal Medicine, Harvard Medical School, New England Deaconess Hospital (now Beth Israel-Deaconess Hospitals), Boston, MA
1985-1986 Visiting Scientist, Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA (laboratory of Dr. Herman Eisen)
1987-1990 Clinical Fellow in Medicine, Harvard Medical School, Brigham and Women's Hospital (Hematology) and Dana Farber Cancer Institute (Medical Oncology), Boston, MA
1988-1992 Postdoctoral Research Fellow, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA (laboratory of Dr. Harvey Lodish)
1990-1992 Instructor in Medicine, Harvard Medical School, Boston, MA
1993-1998 Assistant Professor of Medicine and Cell Biology, Washington University, St. Louis, MO
1999-2007 Associate Professor of Medicine and Cell Biology, Washington University, St. Louis, MO
2008-present Professor of Medicine and Cell Biology, Washington University, St. Louis, MO

Appointments &Committees

1983 Co-Chairperson, Curriculum Review Committee, McGill Medical School
1986-1987 Institutional Review Board, New England Deaconess Hospital, Boston, MA
1993-1995 Compton Scholar Award for entering undergraduates, Natural Sciences and Liberal Arts, Washington University, St. Louis MO
1994-1998 Admissions Committee, Division of Biology and Biomedical Sciences, Washington University, St. Louis, MO
1996-2000 Developmental Biology Steering Committee, Division of Biology and Biomedical Sciences, Washington University, St. Louis, MO
1999-2001 Four Schools Program (Washington University, Duke University, University of Pennsylvania, and Johns Hopkins University), Washington University representative
2003-present Molecular Cell Biology Steering Committee, Division of Biology and Biomedical Sciences, Washington University, St. Louis, MO
2003-present Member, Siteman Cancer Center, Washington University, St. Louis, MO

Board Certification

1986 Diplomate, American Board of Internal Medicine
1989 Diplomate, American Board of Medical Oncology

Honors & Awards

1977-1979 Medical Research Council of Canada Studentship
1980-1981 Faculty Scholarship Award, Department of Medicine, McGill University
1984 James L. Tullis Award, Harvard Medical School
1988-1992 NIH Physician-Scientist Award AG00294, National Institutes of Health
1992-1995 Career Development Award, James S. McDonnell Foundation for Molecular Oncology
1998-1999 NIH Hematology II Study Section
1998-2001 Edward Mallinckrodt, Jr. Foundation Scholar
1999-2003 Established Investigator, American Heart Association
2000 Elected member of American Society for Clinical Investigation
2001 Invited Visiting Professor, Department of Pediatrics, University of Helsinki, Finland
2004-2008 NIH/NCI-F Manpower and Training Study Section
2006-2008 Member, American Cancer Society: Cell Structure and Metastasis Peer Review Committee
2008-2010 Chairperson, American Cancer Society: Cell Structure and Metastasis Peer Review Committee

Editorial Responsibilities

2007-present Editorial Board, Molecular and Cellular Biology
2007-present Associate Editor, Cancer Research

Professional Societies

1980-present American Association for the Advancement of Science
1993-present American Society for Microbiology
1995-2000 American Society of Hematology
2000-present American Society for Cell Biology
2000-present American Society for Clinical Investigation
2007-present The EMT International Association
2008-present American Association of Cancer Research